These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20606430)

  • 1. Pre-clinical myocardial metabolic alterations in chronic kidney disease.
    Fink JC; Lodge MA; Smith MF; Hinduja A; Brown J; Dinits-Pensy MY; Dilsizian V
    Cardiology; 2010; 116(3):160-7. PubMed ID: 20606430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of myocardial glucose utilization in patients with left ventricular dysfunction by means of 18F-FDG dynamic positron tomography and three-compartment analysis.
    Morita K; Katoh C; Yoshinaga K; Noriyasu K; Mabuchi M; Tsukamoto T; Kageyama H; Shiga T; Kuge Y; Tamaki N
    Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):806-12. PubMed ID: 15776232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of Ketosis With Myocardial Glucose Uptake Among Patients Undergoing FDG PET/CT for Evaluation of Cardiac Sarcoidosis.
    Vidula MK; Selvaraj S; Rojulpote C; Bhattaru A; Kc W; Hansbury M; Schubert E; Clancy CB; Rossman M; Goldberg LR; Farwell M; Pryma D; Bravo PE
    Circ Cardiovasc Imaging; 2024 Aug; 17(8):e016774. PubMed ID: 39082134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of myocardial glucose uptake in patients with ischemic cardiomyopathy: application of a new quantitative method using regional tracer kinetic information.
    Wiggers H; Bøttcher M; Nielsen TT; Gjedde A; Bøtker HE
    J Nucl Med; 1999 Aug; 40(8):1292-300. PubMed ID: 10450680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low myocardial glucose uptake in Turner syndrome is unaffected by growth hormone: a randomized, placebo-controlled FDG-PET study.
    Trolle C; Hjerrild B; Mortensen KH; Knorr S; Søndergaard HM; Christiansen JS; Gravholt CH
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):133-40. PubMed ID: 25645325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-clinical myocardial metabolic alterations in chronic kidney disease.
    Saggi SJ; Salifu MO
    Cardiology; 2010; 116(3):157-9. PubMed ID: 20616548
    [No Abstract]   [Full Text] [Related]  

  • 7. Heart failure patients with prediabetes and newly diagnosed diabetes display abnormalities in myocardial metabolism.
    Nielsen R; Jorsal A; Iversen P; Tolbod L; Bouchelouche K; Sørensen J; Harms HJ; Flyvbjerg A; Bøtker HE; Wiggers H
    J Nucl Cardiol; 2018 Feb; 25(1):169-176. PubMed ID: 27473218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased glycolytic metabolism in non-compaction cardiomyopathy by 18F-fluoro-2-deoxyglucose positron emission tomography: new insights into pathophysiological mechanisms and clinical implications.
    Tavares de Melo MD; Giorgi MCP; Assuncao AN; Dantas RN; Araujo Filho JA; Parga Filho JR; Bierrenbach ALS; de Lima CR; Soares J; Meneguetti JC; Mady C; Hajjar LA; Kalil Filho R; Bocchi EA; Salemi VMC
    Eur Heart J Cardiovasc Imaging; 2017 May; 18(8):915-921. PubMed ID: 28379356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
    Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
    J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial glucose uptake in patients with NIDDM and stable coronary artery disease.
    Mäki M; Nuutila P; Laine H; Voipio-Pulkki LM; Haaparanta M; Solin O; Knuuti JM
    Diabetes; 1997 Sep; 46(9):1491-6. PubMed ID: 9287051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of GLP-1 on myocardial glucose metabolism in healthy men during normo- or hypoglycemia.
    Gejl M; Lerche S; Mengel A; Møller N; Bibby BM; Smidt K; Brock B; Søndergaard H; Bøtker HE; Gjedde A; Holst JJ; Hansen SB; Rungby J
    PLoS One; 2014; 9(1):e83758. PubMed ID: 24400077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An abbreviated hyperinsulinemic-euglycemic clamp results in similar myocardial glucose utilization in both diabetic and non-diabetic patients with ischemic cardiomyopathy.
    Fallavollita JA; Luisi AJ; Yun E; deKemp RA; Canty JM
    J Nucl Cardiol; 2010 Aug; 17(4):637-45. PubMed ID: 20387134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial pre-synaptic sympathetic function correlates with glucose uptake in the failing human heart.
    Mongillo M; John AS; Leccisotti L; Pennell DJ; Camici PG
    Eur J Nucl Med Mol Imaging; 2007 Aug; 34(8):1172-7. PubMed ID: 17294189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel effects of the gastrointestinal hormone secretin on cardiac metabolism and renal function.
    Laurila S; Rebelos E; Lahesmaa M; Sun L; Schnabl K; Peltomaa TM; Klén R; U-Din M; Honka MJ; Eskola O; Kirjavainen AK; Nummenmaa L; Klingenspor M; Virtanen KA; Nuutila P
    Am J Physiol Endocrinol Metab; 2022 Jan; 322(1):E54-E62. PubMed ID: 34806426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired global myocardial flow dynamics despite normal left ventricular function and regional perfusion in chronic kidney disease: a quantitative analysis of clinical 82Rb PET/CT studies.
    Fukushima K; Javadi MS; Higuchi T; Bravo PE; Chien D; Lautamäki R; Merrill J; Nekolla SG; Bengel FM
    J Nucl Med; 2012 Jun; 53(6):887-93. PubMed ID: 22562499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo assessment of myocardial glucose uptake by positron emission tomography in adults with the PRKAG2 cardiac syndrome.
    Ha AC; Renaud JM; Dekemp RA; Thorn S; Dasilva J; Garrard L; Yoshinaga K; Abraham A; Green MS; Beanlands RS; Gollob MH
    Circ Cardiovasc Imaging; 2009 Nov; 2(6):485-91. PubMed ID: 19920047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative comparison of analytic and iterative reconstruction methods in 2- and 3-dimensional dynamic cardiac 18F-FDG PET.
    Lubberink M; Boellaard R; van der Weerdt AP; Visser FC; Lammertsma AA
    J Nucl Med; 2004 Dec; 45(12):2008-15. PubMed ID: 15585474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional myocardial blood flow and glucose utilization during fasting and physiological hyperinsulinemia in humans.
    Iozzo P; Chareonthaitawee P; Di Terlizzi M; Betteridge DJ; Ferrannini E; Camici PG
    Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1163-71. PubMed ID: 11934683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of reversible trapping of tracer and the presence of blood metabolites on measurements of myocardial glucose utilization performed by PET and 18F-fluorodeoxyglucose using the Patlak method.
    Herrero P; Dence CS; Sharp TL; Welch MJ; Gropler RJ
    Nucl Med Biol; 2004 Oct; 31(7):883-92. PubMed ID: 15464390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeatable noninvasive measurement of mouse myocardial glucose uptake with 18F-FDG: evaluation of tracer kinetics in a type 1 diabetes model.
    Thorn SL; deKemp RA; Dumouchel T; Klein R; Renaud JM; Wells RG; Gollob MH; Beanlands RS; DaSilva JN
    J Nucl Med; 2013 Sep; 54(9):1637-44. PubMed ID: 23940301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.